Pulmodox100 ml

Pulmodox 100 ml is a bronchodilator medication belonging to the xanthine derivative class, prescribed by physicians to relieve airway narrowing and improve breathing in patients with obstructive respiratory conditions. It works by relaxing the smooth muscles surrounding the bronchi, allowing more air to flow into and out of the lungs.

This generic medicine is commonly recommended for the following conditions:

• Bronchial Asthma: Helps reduce airway constriction and ease breathing difficulties caused by allergic or non-allergic asthma triggers.
• Bronchospasm: Relieves sudden tightening of the muscles in the walls of the bronchioles, which can cause wheezing, coughing, and shortness of breath.
• Chronic Obstructive Pulmonary Disease (COPD): Used as maintenance therapy to manage long-term airflow limitation associated with chronic bronchitis and emphysema.
• Pulmonary Disease with Spastic Bronchial Component: Indicated for other respiratory disorders where spasm of the bronchial muscles contributes to breathing difficulty.

Pulmodox 100 ml should only be used under the guidance and prescription of a registered physician, as the appropriate dose and suitability depend on the patient's age, disease severity, and any coexisting health conditions.

Pulmodox 100 ml is a novel, second-generation bronchodilator within the methylxanthine family. Although chemically related to theophylline, it is structurally distinguished by a dioxolane group attached at the 7th position of the xanthine ring, a difference that significantly alters its pharmacological behavior.

Its primary mechanism involves selective inhibition of the phosphodiesterase-4 (PDE4) enzyme. By blocking PDE4, Pulmodox 100 ml raises intracellular cyclic AMP (cAMP) levels in bronchial smooth muscle cells, leading to relaxation of the airway muscles and subsequent bronchodilation.

Unlike theophylline, Pulmodox 100 ml shows markedly reduced binding affinity for adenosine A1 and A2 receptors. Since many of the cardiac, central nervous system, and gastrointestinal side effects associated with theophylline are mediated through adenosine receptor activity, this reduced affinity is believed to give Pulmodox 100 ml a more favorable safety and tolerability profile compared to older xanthine derivatives.

Additionally, Pulmodox 100 ml has been shown to inhibit platelet-activating factor (PAF) and suppress leukotriene generation, both of which contribute to airway inflammation and bronchoconstriction. This combination of bronchodilation and mild anti-inflammatory activity may add to its overall therapeutic benefit in respiratory disease management.

Pulmodox 100 ml, like other xanthine derivatives, can interact with several medications and substances. These interactions may either raise or lower its blood concentration, affecting both efficacy and safety.

Medicines and Substances to Avoid or Use With Caution

• Other xanthine preparations: Pulmodox 100 ml should not be co-administered with other theophylline/xanthine-based medicines, as this can increase the risk of toxicity.
• Caffeine-containing foods and beverages: Intake of tea, coffee, cola, energy drinks, and chocolate should be limited, since caffeine is chemically related to xanthine derivatives and may add to their stimulant effects.
• Sympathomimetic drugs: Caution is advised when Pulmodox 100 ml is used together with ephedrine or other sympathomimetic agents, as the combination may heighten cardiovascular stimulation.

Drugs That May Increase Pulmodox 100 ml Blood Levels

The following drugs may reduce hepatic clearance of xanthine derivatives, raising plasma levels of Pulmodox 100 ml:

• Erythromycin and Troleandomycin (TAO)
• Lincomycin and Clindamycin
• Allopurinol
• Cimetidine
• Influenza vaccine
• Propranolol

When Pulmodox 100 ml is combined with any of the above, the physician may need to lower the dose to prevent toxicity.

Drugs That May Decrease Pulmodox 100 ml Blood Levels

• Phenytoin and other anticonvulsant medications

Cigarette smoking may also increase the clearance of xanthine derivatives, shortening their plasma half-life. In such cases, a higher dose of Pulmodox 100 ml may be required to maintain the desired therapeutic effect, under physician supervision.

As with other xanthine derivatives, Pulmodox 100 ml may cause side effects in some patients, though it is generally considered better tolerated than older drugs such as theophylline. Most side effects are mild and dose-related.

Commonly Reported Side Effects

• Nausea and vomiting
• Epigastric (upper abdominal) pain
• Headache
• Irritability
• Insomnia (difficulty sleeping)

Less Common but Serious Side Effects

• Tachycardia (rapid heartbeat)
• Extrasystoles (irregular extra heartbeats)
• Tachypnea (abnormally rapid breathing)
• Hyperglycemia (raised blood sugar) — rare
• Albuminuria (protein in urine) — rare

In overdose, more severe effects such as cardiac arrhythmias and tonic-clonic seizures can occur; these may be early warning signs of xanthine toxicity. If any side effects appear, the prescribing physician should be informed promptly. Depending on severity, the physician may temporarily discontinue treatment and, once symptoms resolve, resume therapy at a lower dose if necessary.

Pregnancy

Animal studies have not shown that Pulmodox 100 ml interferes with pre- or postnatal growth. However, well-controlled clinical studies in pregnant women are lacking, so the safety of Pulmodox 100 ml during human pregnancy has not been firmly established. Its use during pregnancy should only be considered after a careful, individualized risk-benefit assessment by the treating physician.

Lactation

Pulmodox 100 ml is contraindicated during breastfeeding. Mothers who are breastfeeding should not take this medicine, and an alternative treatment should be discussed with their doctor.

Effect on Ability to Drive and Use Machines

Pulmodox 100 ml does not impair alertness or concentration at recommended doses and generally does not interfere with the ability to drive or operate machinery. However, individual responses can vary, so caution is advised until a patient knows how the medicine affects them.

Several factors can reduce the hepatic (liver) clearance of xanthine derivatives such as Pulmodox 100 ml, leading to higher blood levels and an increased risk of side effects. These factors include:

• Advanced age
• Congestive cardiac decompensation (heart failure)
• Chronic obstructive pulmonary disease (COPD)
• Severe liver disease
• Concomitant (co-existing) infections
• Concurrent use of drugs such as erythromycin, TAO, lincomycin, clindamycin, allopurinol, cimetidine, influenza vaccine, and propranolol

In patients with any of these risk factors, the physician may reduce the Pulmodox 100 ml dose and, where possible, monitor blood drug concentration to keep it within the safe therapeutic range.

Pulmodox 100 ml should be used with caution in patients with:

• Cardiac (heart) disease
• Hypertension (high blood pressure)
• Elderly age
• Severe hypoxemia (low blood oxygen)
• Hyperthyroidism
• Chronic cor pulmonale
• Congestive heart failure
• Liver disease
• Peptic ulcer disease
• Renal (kidney) impairment

Patients with congestive heart failure require particular caution, as drug clearance is considerably slower in this group; elevated blood levels of Pulmodox 100 ml may persist for an extended period even after treatment is stopped. Importantly, Pulmodox 100 ml carries no known risk of addiction or dependence.

Taking more than the prescribed dose of Pulmodox 100 ml can lead to symptoms of xanthine toxicity. In overdose, the following effects may occur:

• Severe cardiac arrhythmias (abnormal heart rhythms)
• Tonic-clonic seizures (convulsions)

These effects may be the first signs of intoxication and should be treated as a medical emergency. If side effects appear, treatment may need to be temporarily stopped; once all signs and symptoms of toxicity have resolved, the physician may decide to resume therapy at a lower dose if still clinically necessary.

There is no specific antidote for Pulmodox 100 ml overdose. Management is symptomatic and supportive, focused on treating cardiovascular collapse and stabilizing the patient. Anyone suspected of having taken an overdose should seek immediate medical attention.

• Store in a cool, dry place, away from direct light and heat.
• Keep the medicine out of the reach and sight of children.
• Use Pulmodox 100 ml only on the prescription and under the supervision of a registered or specialist physician.
• Do not use the medicine beyond its printed expiry date.